Prinston Recalls Irbesartan and Hydrochlorothiazide Tablets Due to NDEA Impurity
Prinston Pharmaceutical Inc. is recalling Irbesartan and Hydrochlorothiazide tablets because FDA testing found the impurity NDEA above acceptable limits.
- Product
- IRBESARTAN AND HYDROCHLOROTHIAZIDE — IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)
- Category
- Drug
- Distribution
- Distributed nationwide